Clinical Study of IBI362 in Healthy Chinese Male Subjects

NCT04773977 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight/Obesity

Interventions

DRUG: IBI362 liquid formulation
DRUG: IBI362 lyophilized powder

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.